chondrosine: obtained by degradation of chondroitin sulfates; structure given in first source
ID Source | ID |
---|---|
PubMed CID | 71586761 |
CHEBI ID | 190123 |
MeSH ID | M0188394 |
Synonym |
---|
chondrosine |
CHEBI:190123 |
499-14-9 |
(2s,3s,4s,5r,6r)-6-[(2r,3r,4s,5r)-2-amino-4,5,6-trihydroxy-1-oxohexan-3-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid |
660o7jhz39 , |
d-galactose, 2-amino-2-deoxy-3-o-beta-d-glucopyranuronosyl- |
unii-660o7jhz39 |
2-amino-2-deoxy-3-o-(beta-d-glucopyranosyluronic acid)-d-galactose |
chondrosine [who-dd] |
chondrosine [mi] |
WNWNYJSOBYTXFA-IJYCYIJYSA-N |
DTXSID30198141 |
Q27263926 |
Excerpt | Reference | Relevance |
---|---|---|
"The bioavailability of chondrosine was evaluated by its direct measurement as found in the blood plasma following removal of plasma proteins by perchloric acid." | ( HPLC determination of chondrosine in mouse blood plasma after intravenous or oral dose. Igarashi, N; Kusano, S; Ootani, A; Sakai, S; Takeguchi, A; Toida, T; Toyoda, H, 2007) | 0.96 |
Class | Description |
---|---|
O-acyl carbohydrate | A carbohydrate derivative in which the hydrogen atom of at least one alcoholic hydroxy group of a carbohydrate has been replaced by an acyl substituent. |
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 1 (20.00) | 18.7374 |
1990's | 1 (20.00) | 18.2507 |
2000's | 3 (60.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| This Compound (16.71) All Compounds (24.57) |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 5 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |